Showing results (21-30 of 284) with videos related to
Sort By:
Pageof 29
Psychiatrische Praxis|December 1, 2004
[QTc-interval prolongation in therapy with atypical antipsychotics--results of an open, non-randomized survey]Martin Finzel, Mirijam Fric, Gerd LauxPsychiatrische Praxis|September 26, 2003
[Neuroleptics and cognition]Alexander Brunnauer, Elisabeth Geiger, Gerd LauxPsychiatrische Praxis|December 1, 2004
[Erythema multiforme caused by carbamazepine]Carsten Steinmann, Mirijam Fric, Gerd LauxClinical Neuropharmacology|March 5, 2019
The Dopamine Receptor Antagonism of Opipramol: Relevance to Parkinsonism?Verena Rozanski, Gerd Laux, Johannes SchwarzDialogues in Clinical Neuroscience|September 15, 2005
The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressantsPierre Baumann, Sven Ulrich, Gabriel Eckermann, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|September 21, 2017
Erratum to: Abstracts of the WASAD Congress 2017, in conjunction with the Collaborative Research Centers SFB-TRR 58, Fear, Anxiety, Anxiety Disorders 14-16 September, Würzburg, GermanyPeter RiedererThe International Journal of Neuropsychopharmacology|May 26, 2021
Driving Performance Under Treatment of Most Frequently Prescribed Drugs for Mental Disorders: A Systematic Review of Patient StudiesAlexander Brunnauer, Florian Herpich, Peter Zwanzger, et al.Psychiatrische Praxis|January 29, 2009
[Depression and response: impact of personality and cognition]Irmgard David, Alexander Brunnauer, Gerd Laux, et al.Journal of Clinical Psychopharmacology|June 23, 2004
The impact of antipsychotics on psychomotor performance with regards to car driving skillsAlexander Brunnauer, Gerd Laux, Elisabeth Geiger, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|October 5, 2023
L-DOPA-therapy in Parkinson's disease: some personal reflections on L-DOPA therapy from Vienna and BerlinPeter Riederer, Reinhard HorowskiPageof 29